FDA Approved: ZOKINVY — Supplemental Application (Sentynl Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZOKINVY (lonafarnib) from Sentynl Therapeutics, Inc. under NDA 213969. The action approves changes to the labeling a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hutchinson-gilford Progeria Syndrome
• Processing-deficient Progeroid Syndrome

Drugs mentioned

• Zokinvy (Lonafarnib)

Snippet

SUPPL AP for ZOKINVY (LONAFARNIB)